Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(TSX:
BLCO
)
22.14
+0.56 (+2.59%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
Next >
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
September 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
September 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
August 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®
August 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
August 02, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Solidifies Leadership Team
August 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
July 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
July 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
Bausch + Lomb Will Acquire XIIDRA®
June 30, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
June 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting
June 08, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States
June 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States
June 05, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Key Leadership Changes
June 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
May 18, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance
May 03, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Releases Annual Environmental, Social and Governance Report
May 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
April 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
April 25, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
April 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting
April 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
April 18, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3
April 17, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals
April 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology
March 22, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.